SCHEMBL1756085

SCHEMBL1756085

OC1C[C@@H](O)CCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22727920 1.00
SCHEMBL3915694 1.00
SCHEMBL20530472 1.00
SCHEMBL20530477 1.00
SCHEMBL22030681 1.00
SCHEMBL8163032 1.00
SCHEMBL22030685 1.00
SCHEMBL848613 0.80
SCHEMBL28796003 0.80 THRB (0.33)
SCHEMBL45273 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017068068-A1 USE OF GLYCOSIDES TO INCREASE HAIR MASS L'OREAL (FR) 2017-04-27 WO disclosed
WO-2015159118-A2 COMPOSITIONS OF A CARBOHYDRATE VACCINE FOR INDUCING IMMUNE RESPONSES AND USES THEREOF IN CANCER TREATMENT OBI PHARMA, INC. (TW) 2015-10-22 WO disclosed
WO-2014107652-A2 VACCINES WITH HIGHER CARBOHYDRATE ANTIGEN DENSITY AND NOVEL SAPONIN ADJUVANT OBI PHARMA (TW) 2014-07-10 WO disclosed
EP-2441515-A1 Catalyst and method of manufacture General Electric Company (US) 2012-04-18 EP disclosed